Literature DB >> 24649037

Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review).

Xianglin Dong1, Shaolin Mao1, Hao Wen2.   

Abstract

It was previously demonstrated that the main cause behind keloid formation may be keloid fibroblast abnormalities, which are closely associated with the microenvironment of the keloid lesion. The post-traumatic and chronic inflammation of the keloid lesion area suggest that inflammatory mediators play an important role in the keloid microenvironment and are crucial for keloid fibroblast abnormalities. In this study, we hypothesized that the mechanism underlying keloid formation may involve the continuous upregulation of proinflammatory gene expression in keloid lesions. This hypothesis may explain the inflammatory response, invasive growth and recurrence following resection of keloids, as well as the selective localization of keloids in specific parts of a patient's body and the differences in localization among different patients.

Entities:  

Keywords:  keloid formation; proinflammatory genes; skin lesion

Year:  2013        PMID: 24649037      PMCID: PMC3917036          DOI: 10.3892/br.2013.169

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  36 in total

Review 1.  Keloids--clinical diagnosis, pathogenesis, and treatment options.

Authors:  Alexander G Marneros; Thomas Krieg
Journal:  J Dtsch Dermatol Ges       Date:  2004-11       Impact factor: 5.584

2.  p53 and apoptosis alterations in keloids and keloid fibroblasts.

Authors:  D A Ladin; Z Hou; D Patel; M McPhail; J C Olson; G M Saed; D P Fivenson
Journal:  Wound Repair Regen       Date:  1998 Jan-Feb       Impact factor: 3.617

3.  Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts.

Authors:  D V Messadi; A Le; S Berg; G Huang; W Zhuang; C N Bertolami
Journal:  Front Biosci       Date:  1998-02-15

4.  Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.

Authors:  K De Bosscher; M L Schmitz; W Vanden Berghe; S Plaisance; W Fiers; G Haegeman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Morphological and immunochemical differences between keloid and hypertrophic scar.

Authors:  H P Ehrlich; A Desmoulière; R F Diegelmann; I K Cohen; C C Compton; W L Garner; Y Kapanci; G Gabbiani
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

6.  About strawberry, crab claws, and the Sir James Black's invention. Hypothesis: can we battle keloids with propranolol?

Authors:  Charles Jean G de Mesquita
Journal:  Med Hypotheses       Date:  2009-09-15       Impact factor: 1.538

7.  DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.

Authors:  Sachio Makino; Norisato Mitsutake; Masahiro Nakashima; Vladimir A Saenko; Akira Ohtsuru; Kazuo Umezawa; Katsumi Tanaka; Akiyoshi Hirano; Shunichi Yamashita
Journal:  J Dermatol Sci       Date:  2008-04-11       Impact factor: 4.563

8.  Keloids: enigma of the plastic surgeon.

Authors:  H E Pierce
Journal:  J Natl Med Assoc       Date:  1979-12       Impact factor: 1.798

9.  Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars.

Authors:  H Nakaoka; S Miyauchi; Y Miki
Journal:  Acta Derm Venereol       Date:  1995-03       Impact factor: 4.437

10.  Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings.

Authors:  Chenyu Huang; Satoshi Akaishi; Hiko Hyakusoku; Rei Ogawa
Journal:  Int Wound J       Date:  2012-11-22       Impact factor: 3.315

View more
  30 in total

Review 1.  [Therapy of hypertrophic scars and keloids].

Authors:  R Aschoff
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 2.  Novel Insights on Understanding of Keloid Scar: Article Review.

Authors:  Walid Mari; Sami G Alsabri; Najib Tabal; Sara Younes; Abdulamagid Sherif; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2016-11-30

3.  Mast cell chymase in keloid induces profibrotic response via transforming growth factor-β1/Smad activation in keloid fibroblasts.

Authors:  Xianglin Dong; Chuanshan Zhang; Shaolin Ma; Hao Wen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition.

Authors:  Zhaoyi Li; Libo Yin; Yuanyuan Li; Yi Cao; Haifeng Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

5.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

6.  Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate.

Authors:  Ke-Xin Song; Shu Liu; Ming-Zi Zhang; Wei-Zhong Liang; Hao Liu; Xin-Hang Dong; You-Bin Wang; Xiao-Jun Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Nov.       Impact factor: 3.066

7.  Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes.

Authors:  Latha Satish; Alexander Evdokiou; Eleni Geletu; Jennifer M Hahn; Dorothy M Supp
Journal:  Burns Trauma       Date:  2020-02-27

Review 8.  New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects.

Authors:  Bernardo Hochman; Felipe Contoli Isoldi; Fabianne Furtado; Lydia Masako Ferreira
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-02-10

9.  Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway.

Authors:  Bin Zhao; Hao Guan; Jia-Qi Liu; Zhao Zheng; Qin Zhou; Jian Zhang; Lin-Lin Su; Da-Hai Hu
Journal:  Int J Mol Med       Date:  2016-12-01       Impact factor: 4.101

10.  Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.

Authors:  Limin Luo; Jun Li; Han Liu; Xiaoqing Jian; Qianlei Zou; Qing Zhao; Qu Le; Hongdou Chen; Xinghua Gao; Chundi He
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.